One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v130.suppl_1.1495.1495
Copy DOI Journal: Blood |  Publication Date: Jun 25, 2021 |
 Citations: 1 |
Affiliation: European Neuroendocrine Tumor Society, Regeneron (United States), Cleveland Clinic, Hospital Universitario 12 De Octubre, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Instituto de Investigación Biomédica de Salamanca, Hospital Universitario Fundación Jiménez Díaz, University of California, Los Angeles, Jena University Hospital, University Hospital Würzburg, University Hospital Schleswig-Holstein, University Hospital Cologne, University Hospital Frankfurt, Hospital Universitario Puerta de Hierro Majadahonda, Cornell University, South Texas Accelerated Research Therapeutics, University of Pennsylvania, Vall d'Hebron Hospital UniversitariSafety and Preliminary Antitumor Activity of the Anti-PD-1 Monoclonal Antibody REGN2810 Alone or in Combination with REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with B-Lymphoid Malignancies
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
